"Successor Candidates Exist, But Won't Take Over" Problem - Nikkei Medical

SUMMARY

According to Google News: A report from "Successor Candidates Exist, But Won't Take Over" - Nikkei Medical is being conveyed. This information is useful for management decisions regarding hospitals, clinics, and medical corporations as the latest trend in the medical industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

The "mismatch in intra-family succession" where succession does not occur even with physician children is,one of the most serious business suspension risksin modern medical management. Due to the specialization of the board certification system, cases where the parent's specialty area and the child's career diverge are increasing, highlighting the reality that simple "blood ties" are not enough to pass on the management baton.

In the context of medical M&A, this situation should be viewed asa precursor to the "succession deadline."The reasons why successor candidates refuse often include not only the psychological burden of management responsibility but also concerns about the existing staff composition and facility obsolescence. By considering a transfer to a third party as an option, a flexible exit strategy is required that guarantees the continuity of the corporation's medical practice while providing "career freedom as a physician" to family members and "maintaining medical infrastructure" for the community.

What management should face isthe reality that the expectation of "they will eventually succeed me" is actually diminishing the clinic's transfer value.If patient attrition and equipment obsolescence progress before the candidate's decision is solidified, even the opportunity for a third-party transfer will be missed. Considering succession schemes to external capital or younger physicians early on is also a "wise strategic retreat" to protect intra-family relationships.

News Highlights

Nikkei Medical reported that the issue of “successor candidates existing but refusing to take over” is becoming apparent in medical institutions. This suggests not just a shortage of successors, but also the intentions of candidates and the difficulties of succession. The importance of specific schemes unique to medical corporations (like transfer of equity shares, changes in members, return of funds, etc.), appropriate business valuation that comprehensively assesses medical profits, fixed assets, licenses, staff, and patient base, and post-succession follow-up is being highlighted once again.

M&A Medical Editorial Department’s Perspective

The situation where “successors exist but do not take over” suggests a new phase in the business succession of medical institutions. It is not merely a generational change, but the background leading to the candidate’s decision not to “choose” succession likely involves complex factors such as the increasing complexity of medical institution management, long working hours, heavy responsibilities, or profitability issues. For example, in small to medium-sized clinics supporting regional healthcare, even with the long-standing achievements and trust from the community of the current director, it is presumed that an increasing number of successor candidates are declining succession after considering their own career plans and work-life balance. In such circumstances, third-party succession through M&A becomes a realistic option. However, even then, not just a simple transfer, but the construction of a scheme from a more multifaceted perspective is required, such as the continuity of regional healthcare and the maintenance of staff employment. In particular, when considering M&A as an exit strategy, the valuation of not only medical profits but also the patient base cultivated over many years and intangible assets such as licenses becomes crucial.

Points Raised by This News

The “refusal to take over” by successor candidates may be due to a decline in the attractiveness or increased burden of managing medical institutions.
Understanding schemes such as the transfer of equity shares, changes in members, and return of funds for medical corporations is crucial for the success of succession.
Appropriate business valuation of intangible assets, including licenses and patient base, not just medical profits, is essential.
The establishment of a comprehensive support system that looks ahead to stable operation after succession is required.

Practical Questions Arising from This News

What are the specific reasons why successor candidates refuse to take over?
What are the specific procedures for transferring equity shares or changing members of a medical corporation?
When succeeding through M&A, how is staff employment protected?

If You Feel “Should I Consult Too?”

Medical institution managers facing situations such as “successors exist, but succession is not going well” or “candidates are not enthusiastic about succession” are strongly advised to consult with experts early on. Instead of solely focusing on finding a successor, considering diverse options including M&A, and receiving advice on business valuation from an objective perspective and on constructing a scheme that can maintain contributions to regional healthcare will pave the way for management stabilization and smooth business succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here

📌 Source (Primary Information)

“Successor Candidates Exist, But Won’t Take Over” Problem – Nikkei Medical

Source: Google News: Successor Clinic

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →